Live from the NIH registry
Studies recruiting near Huntsville right now
Top 25 of 92 recruiting studies, sorted by proximity — each links to its official registry page
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Heart Center Rsrch_Hunstville — Huntsville, Alabama (3.9 mi)
· Sponsor: Novo Nordisk A/S
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma, Relapsed/Refractory Multiple Myeloma
Phase 2
Interventional 100 participants sought
Clearview Cancer Institute — Huntsville, Alabama (3.9 mi)
· Sponsor: C4 Therapeutics, Inc.
Pivotal Study for the Cardiac Performance System (CPS)
Cardiovascular Diseases
N/A
Observational 1,000 participants sought
Huntsville Hospital Heart Center — Huntsville, Alabama (3.9 mi)
· Sponsor: Sensydia Corporation
Protocol for Collecting, Banking and Distributing Human Tissue Samples: St. Jude Children's Research Hospital Tissue Resources Core Facility
Normal and Diseased Tissue and Body Fluids Samples
N/A
Observational 100,000 participants sought
St. Jude Clinic at Huntsville Hospital for Women & Children — Huntsville, Alabama (3.9 mi)
· Sponsor: St. Jude Children's Research Hospital
Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia
Waldenstrom Macroglobulinemia
N/A
Observational 111 participants sought
Clearview Cancer Institute — Huntsville, Alabama (3.9 mi)
· Sponsor: BeiGene
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
End Stage Kidney Disease
Phase 2, Phase 3
Interventional 3,110 participants sought
Nephrology Consultants, LLC — Huntsville, Alabama (3.9 mi)
· Sponsor: CSL Behring
Collection and Distribution of Biospecimens for Novel Research Uses
Cancer, Healthy
N/A
Observational 10,000 participants sought
iSpecimen — Huntsville, Alabama (3.9 mi)
· Sponsor: iSpecimen Inc
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
Heart Failure - NYHA II - IV
N/A
Interventional 850 participants sought
Heart Center Research, LLC — Huntsville, Alabama (3.9 mi)
· Sponsor: Boston Scientific Corporation
Tracking Results of Ablations to Combat AF Registry Generation 2
Atrial Fibrillation
N/A
Observational 10,000 participants sought
Huntsville Hospital — Huntsville, Alabama (3.9 mi)
· Sponsor: AtriCure, Inc.
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
Type II Diabetes Mellitus
Phase 2
Interventional 240 participants sought
AES - DRS - Optimal Research Alabama - Huntsville — Huntsville, Alabama (3.9 mi)
· Sponsor: Corxel Pharmaceuticals
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Colorectal Cancer
Phase 2
Interventional 140 participants sought
Clearview Cancer Institute - Huntsville - Cci Drive /ID# 278621 — Huntsville, Alabama (3.9 mi)
· Sponsor: AbbVie
PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Proteinuric Kidney Diseases
Phase 2
Interventional 132 participants sought
Nephrology Consultants, LLC — Huntsville, Alabama (3.9 mi)
· Sponsor: Boehringer Ingelheim
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Chronic Kidney Disease
Phase 3
Interventional 7,000 participants sought
Research Site — Huntsville, Alabama (3.9 mi)
· Sponsor: AstraZeneca
Prevail Global Study
Coronary Artery Disease
N/A
Interventional 1,205 participants sought
Huntsville Hospital — Huntsville, Alabama (3.9 mi)
· Sponsor: Medtronic Vascular
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
Heart Center Research LLC — Huntsville, Alabama (3.9 mi)
· Sponsor: Amgen
Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps
Chronic Rhinosinusitis Without Nasal Polyps
Phase 3
Interventional 84 participants sought
North Alabama ENT — Huntsville, Alabama (3.9 mi)
· Sponsor: Optinose US Inc.
RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive
HER2-positive Breast Cancer
Phase 2, Phase 3
Interventional 650 participants sought
Clearview Cancer Institute — Huntsville, Alabama (3.9 mi)
· Sponsor: Hoffmann-La Roche
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
Proteinuric Kidney Disease
Phase 2
Interventional 74 participants sought
Research Site — Huntsville, Alabama (3.9 mi)
· Sponsor: Maze Therapeutics
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Huntsville, Alabama (3.9 mi)
· Sponsor: TG Therapeutics, Inc.
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
Migraine
Phase 4
Interventional 1,335 participants sought
Apogee Clinical Research — Hazel Green, Alabama (16.7 mi)
· Sponsor: Mayo Clinic
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Cardiovascular Disease
Phase 3
Interventional 15,100 participants sought
Research Site — Huntsville, Alabama (3.9 mi)
· Sponsor: AstraZeneca
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Huntsville, Alabama (3.9 mi)
· Sponsor: Alnylam Pharmaceuticals
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Rehabilitation and Neurological Services /ID# 270782 — Huntsville, Alabama (3.9 mi)
· Sponsor: AbbVie
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Heart Center Research, LLC — Huntsville, Alabama (3.9 mi)
· Sponsor: Duke University
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
Phase 3
Interventional 11,300 participants sought
Research Site — Huntsville, Alabama (3.9 mi)
· Sponsor: AstraZeneca